Delivery Order SPE2DB22D3501-SPE2DB25FVJ02
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,992.55 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets. The contract has an ultimate completion date of May 14, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,475.20 firm fixed-price delivery order contract is for the supply of Descovy 200-25 mg tablets to support military healthcare programs. The contract has an ultimate completion date of March 24, 2025 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, SPE2DB20D1047|SPE2DB25FF54R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,894.80 firm-fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, a prescription medication. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,248.92 firm-fixed-price delivery order covers the supply of Descovy 200-25 mg tablets for an ultimate completion date of November 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $23,042.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB20D1100|SPE2DB25FC0F8) for the supply of the medication Descovy 200-25 mg tablet, and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, with an ID of SPE2DB24D2010|SPE2DB25FZYF7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $22,330.13 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, with a period of performance through May 2, 2025. The award is not set-aside and represents part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00....
This federal contract award, valued at $12,735.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Descovy 200-25 mg tablet medication. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through May 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This award is not designated as a set-aside contract, suggesting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,677.03 firm fixed-price delivery order, which does not have a set-aside designation, is for the supply of Descovy 200-25mg tablets. The contract has an ultimate completion date of August 30, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB25D2207|SPE2DB25FQQUP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,637.09 firm fixed-price delivery order is for the supply of 4,568,060,965 tablets of the medication Descovy 200-25 mg. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $47,229.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Descovy 200-25 mg tablets, a prescription medication. It is a firm-fixed-price contract without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...